Low-molecular-weight iron dextran in the management of renal anaemia in patients on haemodialysis--the IDIRA Study.

Nephron. Clinical practice

Volumn 114, Issue 1, 2010, Pages

  Rath, Thomas ^a   Florschütz, Kai ^a   Kalb, Klaus ^a   Rothenpieler, Uwe ^a   Schletter, Jörg ^a   Seeger, Wolfgang ^a   Zinn, Stefan ^a  

^a Westpfalz Klinikum GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANEMIC AGENT; DRUG DERIVATIVE; ERYTHROPOIETIN; FERRIC GLUCONATE; FERRIC ION; FERRITIN; IRON DEXTRAN; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN;

AGED; ANEMIA; ARTICLE; BLOOD; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; PROSPECTIVE STUDY; RENAL REPLACEMENT THERAPY;

AGED; ANEMIA; ERYTHROPOIETIN; FEMALE; FERRIC COMPOUNDS; FERRITINS; HEMATINICS; HUMANS; IRON-DEXTRAN COMPLEX; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL DIALYSIS;

EID: 77952306943     PISSN: None     EISSN: 16602110     Source Type: Journal    
DOI: 10.1159/000253958     Document Type: Article

References (0)